[logo] HealthTree Foundation
more_vert
close
person Sign In / Create Account

Common Induction Therapies: How Does the Oncologist or Specialist Decide?

Common Induction Therapies: How Does the Oncologist or Specialist Decide? image

Common Induction Therapies: How Does the Oncologist or Specialist Decide?

Webinar
event Sep 29, 2021 / 01:00PM - 02:00PM EDT
link icon facebook logo X logo linkedin logo reddit logo email icon

Event Description

With the amazing research being made in the myeloma field, there are now more front-line therapies than ever. What are your options? How does your doctor determine which induction therapy is right for you? Join Dr. Diamond as he walks us through this complex decision. 

Schedule & Agenda

Event panelist Audrey Burton-Bethke
01:00 PM
Introductions
Audrey Burton-Bethke
Audrey presents the meeting agenda and introduces our featured speaker. 
Event panelist Dr. Benjamin Diamond
01:05 PM
Presentation
Dr. Benjamin Diamond
Dr. Ben Diamond shares questions to the following questions about induction therapy:  What are your options? How does your doctor determine which induction therapy is right for you?
Event panelist Audience
01:40 PM
Questions and Answers
Audience
Ask your questions to Dr. Diamond and get them answered! 

Speakers & Moderators

The panelist Audrey Burton-Bethke
Audrey Burton-Bethke

Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.

Read Bio
The panelist Benjamin Diamond, MD
Benjamin Diamond, MD

Dr. Diamond is a hematologist/oncologist who specializes in the treatment of plasma cell disorders including monoclonal gammopathy of undetermined significance, smoldering myeloma, and multiple myeloma. He completed fellowship at Memorial Sloan Kettering Cancer Center, spending a year as chief fellow, and is now an Assistant Professor at Sylvester Comprehensive Cancer Center is a member of the Myeloma Genomics Laboratory participating in translational research. His research interests include utilization of minimal residual disease (MRD)-guided approaches to clinical decision-making, maintenance therapy, and the genomics of multiple myeloma and secondary malignancies that occur in patients treated for multiple myeloma.

Read Bio
HealthTree Connect Icon

Join the Conversation

This event is part of the Newly Diagnosed group in HealthTree Connect, a social media platform for people with blood cancer. If you want to connect with other patients and caregivers and talk about this topic, join HealthTree Connect.

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

Thanks to our sponsors:
Johnson and Johnson logo
Sanofi logo
Adaptive logo
Pfizer logo
GSK logo
Regeneron logo
All HealthTree resources available anywhere, anytime
Download our App
Download iOS App Download Android App
iphone app mockup
newsletter icon

Get the Latest Multiple Myeloma Updates, Delivered to You.

By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.